David R Epstein
CIK 1445826 · CEO · last filed 2026-08-05
David R Epstein is a CEO who has filed 104 SEC Form 4 insider transactions across 9 companies since 2008. The most recent filing shows the insider sold $16.1K of TEM on Aug 5, 2026. Across all open-market trades the lifetime net is −$3.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions. 24 SEC filings were submitted jointly with Tempus AI, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.01M
9
104
-$3.41M
Filer Profile
DELRAY BEACH, FL 33483
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEM | Director | 31,094 | $64.66 | $2.01M | -$294.1K | 17 | 2026-08-05 |
| Seagen Inc. (SGEN) Delisted | CEO | 0 | $228.74 | $0 | -$2.26M | 4 | 2023-12-15 |
| SNTI | Director | — | $0.34 | — | $0 | 1 | 2022-07-15 |
| Evelo Biosciences, Inc. (EVLO) Delisted | Director | 4,697 | $0.00 | $0 | $120.7K | 19 | 2022-06-30 |
| Axcella Health Inc. (AXLA) Delisted | Director | 8,390 | $0.40 | $3.4K | $786.7K | 29 | 2022-06-03 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | 4,720,012 | $0.08 | $391.8K | -$1.77M | 10 | 2022-05-13 |
| INTERNATIONAL FLAVORS & FRAGRANCES INC (IFFT) Delisted | Director | — | $47.56 | — | $0 | 5 | 2020-11-04 |
| IFF | Director | — | $86.46 | — | $0 | 9 | 2018-05-03 |
| Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted | Director | — | — | — | $0 | 1 | 2008-09-24 |
Recent Filings
104 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-05 | TEM | Sell (S) | −370 | -$16.1K | EDGAR |
| 2026-08-03 | TEM | Notice (144) | −990 | -$43.4K | EDGAR |
| 2026-06-03 | TEM | Sell (S) | −250 | -$12.3K | EDGAR |
| 2026-05-26 | TEM | Grant (A) | +5,913 | $0 | EDGAR |
| 2026-03-04 | TEM | Sell (S) | −250 | -$12.7K | EDGAR |
| 2026-03-02 | TEM | Notice (144) | −870 | -$46.3K | EDGAR |
| 2026-02-04 | TEM | Sell (S) | −370 | -$22.0K | EDGAR |
| 2025-12-03 | TEM | Sell (S) | −250 | -$18.9K | EDGAR |
| 2025-11-05 | TEM | Sell (S) | −370 | -$33.3K | EDGAR |
| 2025-11-03 | TEM | Notice (144) | −990 | -$89.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.